Charles Drake, MD, PhD

VP, Immno-Oncology

J&J Innovative Medicine

Sessions:

Speaker Cell Therapy in a Crowded IO Landscape: Where Will Each Modality Have the Greatest Impact?

Speaker T-Cell Engager Combination Strategies in Prostate Cancer: Clinical Lessons from PAS + Chemo, ADCs, and CD28 Co-Stimulation